Inactive Instrument

LA JOLL Stock Nasdaq

Equities

End-of-day quote Nasdaq Other stock markets
- ^USD	-

La Jolla : Pharmaceutical Company : Receives Positive Opinion from European Orphan Committee for LJPC-401	15-09-11	BU
La Jolla : Pharmaceutical Company : Announces Pricing of Underwritten Offering of Common Stock	15-09-10	BU
La Jolla : Pharmaceutical Company : Announces Proposed Underwritten Offering of Common Stock	15-09-09	BU
La Jolla : Pharmaceutical Company : Receives Orphan Drug Designation for Two Novel Compounds for Fibrodysplasia Ossificans Progressiva	15-08-18	BU
La Jolla : Pharmaceutical Company : and Vanderbilt University Enter Exclusive Research and License Agreement Covering Novel BMP Type-I Receptor Inhibitors	15-08-18	BU

Sector